文献速递血液净化与透析

自动化腹膜透析与临时血液透析用于终末期肾病患者紧急起始透析的随机对照试验

A Randomized Controlled Trial Comparing Automated Peritoneal Dialysis and Hemodialysis for Urgent-Start Dialysis in ESRD.
PubMed 文献 · Kidney Int Rep · 2024-06-27

这项多中心随机对照试验纳入116例需紧急透析的终末期肾病患者,比较自动化腹膜透析(APD)与临时血液透析(HD)在12个月内的透析相关并发症。结果显示APD组1年透析相关并发症发生率显著低于HD组(25.9% vs 56.9%,P=0.001),且初始住院总直接医疗费用显著更低,而导管生存率、无腹膜炎生存率和患者生存率无显著差异。

要点

  • APD较临时HD显著降低紧急起始透析患者1年透析相关并发症发生率。
  • APD组初始住院总直接医疗费用低于HD组,但首次住院时长无差异。
  • 两组PD导管生存率、无腹膜炎生存率和患者生存率均无显著差异。

核心结论

  • 对需紧急起始透析的ESRD患者,APD较HD的透析相关并发症发生率更低、初始住院费用更低。
  • 两组PD导管生存率、无腹膜炎生存率和患者生存率无显著差异。

研究设计与样本

  • 多中心随机对照试验,纳入中国11家医院116例需紧急透析的ESRD患者,随机分为APD组或HD组。
  • 患者先接受2周APD或经临时中心静脉导管的HD治疗,随后转为维持性腹膜透析,随访12个月共8次访视。
  • 主要结局为透析相关并发症。

主要发现

  • APD组1年透析相关并发症发生率为25.9%,HD组为56.9%(P=0.001)。
  • 两组PD导管生存率无显著差异(P=0.388)。
  • 两组无腹膜炎生存率无显著差异(P=0.335)。
  • 两组患者生存率无显著差异(P=0.329)。
  • APD组初始住院总直接医疗费用为27,008.39元,HD组为42,597.54元(P=0.001);首次住院时长无显著差异(P=0.424)。

临床怎么用

  • 对需紧急起始透析的ESRD患者,可优先考虑APD以降低透析相关并发症和初始住院费用。
  • 选择APD时需评估腹膜透析置管可行性及后续维持性腹膜透析条件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Peritoneal dialysis (PD) shows promise for urgent-start dialysis in end-stage renal disease (ESRD), with automated PD (APD) having advantages. However, there is limited multicenter randomized controlled trial (RCT) evidence comparing APD with temporary hemodialysis (HD) for this indication in China. METHODS: This multicenter RCT enrolled 116 patients with ESRD requiring urgent dialysis from 11 hospitals, randomized to APD or HD. Patients underwent a 2-week treatment with APD or HD via a temporary central venous catheter (CVC), followed by a maintenance PD. Outcomes were assessed over 12 months during 8 visits. The primary outcome was dialysis-related complications. RESULTS: The 1-year incidence of dialysis-related complications was significantly lower in the APD group than in the HD group (25.9% vs. 56.9%, P = 0.001). No significant differences were found between the groups in terms of PD catheter survival rates (P = 0.388), peritonitis-free survival rates (P = 0.335), and patient survival rates (P = 0.329). In terms of health economics, the total direct medical cost of the initial hospitalization for patients with ESRD was significantly lower in the APD group (27,008.39 CNY) than in the HD group (42,597.54 CNY) (P = 0.001), whereas the duration of the first hospital stay showed no significant difference (P = 0.424). CONCLUSION: For patients with ESRD needing urgent initiation of dialysis, APD was associated with a lower incidence of dialysis-related complications and lower initial hospitalization costs compared with HD, with no significant differences in PD catheter survival rate, peritonitis-free survival rates, or patient survival rates. These findings can guide clinical decision-making for the optimal dialysis modality for patients requiring urgent dialysis initiation.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Jin H, Fang W, Wang L, et al. A Randomized Controlled Trial Comparing Automated Peritoneal Dialysis and Hemodialysis for Urgent-Start Dialysis in ESRD. Kidney Int Rep. 2024. PMID: 39291207. doi:10.1016/j.ekir.2024.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。